Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 141.08M P/E - EPS this Y 25.70% Ern Qtrly Grth -
Income -26.6M Forward P/E -42.10 EPS next Y 92.30% 50D Avg Chg 20.00%
Sales 178.28M PEG - EPS past 5Y - 200D Avg Chg 82.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -23.00%
Recommedations 1.90 Quick Ratio 0.80 Shares Outstanding 43.07M 52W Low Chg 269.00%
Insider Own 15.57% ROA -24.20% Shares Float 35.69M Beta 1.19
Inst Own 38.40% ROE - Shares Shorted/Prior 4.70M/4.59M Price 4.21
Gross Margin 88.92% Profit Margin -13.18% Avg. Volume 358,162 Target Price 12.57
Oper. Margin -12.45% Earnings Date Nov 6 Volume 141,569 Change -5.39%
About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD, Inc. News
11/13/24 US Growth Companies With High Insider Ownership
11/12/24 LifeMD to Participate in Three Investor Conferences During November
11/12/24 Top 3 Undervalued Small Caps With Insider Action In US For November 2024
11/09/24 LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations
11/07/24 LifeMD Reports Third Quarter 2024 Results
11/06/24 LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
10/24/24 LifeMD launches TestoRx, direct to consumer testosterone replacement therapy
10/24/24 LifeMD® to Report Third Quarter 2024 Financial Results on November 7
10/23/24 LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
10/12/24 LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions
09/24/24 LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
09/19/24 LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
08/26/24 LifeMD to Participate in Three Investor Conferences During September
08/10/24 Analyst Estimates: Here's What Brokers Think Of LifeMD, Inc. (NASDAQ:LFMD) After Its Second-Quarter Report
08/07/24 LifeMD Reports Second Quarter 2024 Results
07/31/24 Investors in LifeMD (NASDAQ:LFMD) have seen fantastic returns of 955% over the past five years
07/30/24 LifeMD to Report Second Quarter 2024 Financial Results on August 7
07/25/24 LifeMD to Participate in Two Investor Conferences During August
07/10/24 Unveiling US Growth Companies With High Insider Ownership In July 2024
07/04/24 LifeMD, Inc. (NASDAQ:LFMD): When Will It Breakeven?
LFMD Chatroom

User Image ManyMoney9296 Posted - 3 hours ago

$LFMD anyway, I believe in management, in company, in product.

User Image ManyMoney9296 Posted - 5 hours ago

$LFMD if they can’t sell WS, just need get rid of it, by selling to management for cheap

User Image gambiteer Posted - 6 hours ago

$LFMD I’m so glad I sold my position in this company, I was looking into $QUBT and noticed that Schreiber is involved in that company as well, seems like LifeMD’s CEO has been distracted the last couple of months. $LFMD really needs a serious CEO that tightens the ship and gets rid of WorkSimpli, in the meantime $HIMS is a way better option as a telehealth/GLP-1 play.

User Image xbizo Posted - 1 day ago

@LoverGirl Although I took it on the chin with $LFMD this year, company is hitting all its objectives. Should be $20. Thank traders and algos playing on fear for this gift entry price. I think the business model is strong and sticky. Lilly and Amazon are not playing in the same pool. imo, 2025 will be a great year. 3x, maybe 5x from here. DYOD people. This one is being played.

User Image ManyMoney9296 Posted - 2 days ago

$LFMD sooner or later this company will be recognized by market

User Image LoverGirl Posted - 2 days ago

$LFMD Went to the 7s and knocked back down to the 5s…this stock can’t catch a break,…

User Image AceBeck Posted - 3 days ago

$LFMD Expected 4 figure today, maybe tomorrow

User Image Cybtrader Posted - 3 days ago

$LFMD Based on HIMS 9% move and large, short squeeze occurring wouldn't it make sense ...Possibly LFMD was heading to 7 soon ?

User Image Payshentz Posted - 3 days ago

$LFMD Yes, it's time to run!

User Image FringDook Posted - 3 days ago

$LFMD time to run

User Image gambiteer Posted - 3 days ago

$LFMD sold my whole position, might jump in later

User Image Annaba514 Posted - 3 days ago

$LFMD back to 4$..shiit penny stock stay penny stock forever..

User Image Payshentz Posted - 5 days ago

$LFMD Looks like sizable and broad increase in institutional investment this month. I would expect the price to follow, especially given all of the progress being made to expand services.

User Image gambiteer Posted - 6 days ago

$LFMD we’re lucky it can’t be shorted today, otherwise it would be under $5 for sure

User Image AceBeck Posted - 6 days ago

$LFMD 4 next week would be great

User Image Annaba514 Posted - 6 days ago

$LFMD this shiit down more than $HiMS..

User Image gambiteer Posted - 6 days ago

$LFMD stock got f*cked

User Image gazza75799 Posted - 6 days ago

$LFMD trump pump is now done. What's next?

User Image Annaba514 Posted - 6 days ago

$LFMD incredebel.. from 7.5$ to 5.6$ in 2 days..

User Image LoverGirl Posted - 6 days ago

$LFMD That’s easy for him to just say….,

User Image javafromjava Posted - 6 days ago

$LFMD Justin Schreiber when asked about Amazon; "Zero impact on our business" It seems this company has been significantly undervalued for a while.

User Image biggestloser101 Posted - 6 days ago

$LFMD amazon goes ed pill. and this goes down. this company barely makes anything on ed.

User Image Richie1cash Posted - 6 days ago

$LFMD This is exactly the pullback I was looking for. Would love to see LFMD and HIMS merge to challenge the $AMZN obstacle.

User Image TTT34 Posted - 6 days ago

$LFMD I like your solidarity with $HIMS Friends forever 😋

User Image Phil1973 Posted - 6 days ago

$LFMD Unless you think LFMD is an acquisition target, the AMZN news will be an overhang on the psychology of this stock moving forward. Perception or reality, doesn't really matter either way. It's an albatross.

User Image AceBeck Posted - 1 week ago

$LFMD 5 tomorrow

User Image Elevate1 Posted - 1 week ago

$LFMD Amazon has focused on its pharmacy operations. Teleheath is very tricky to manage unless you own the doctors and they are working for the company. LFmd is proving a fully integrated from Fullfillment to owning the prescriber is much more successful than the way teledocs and the normal teleheath players cannot compete. The bulk of the new customers are coming from virtual primary care to get the appropriate advice on the weight loss drugs. LFmd gets nearly 50% of it business on private insurance reimbursement and when Medicare starts jan1 they will be getting 75%. These drugs are more than weight loss their main mechanism of action is raising the super oxide dismutase2 levels in the mitochondria of the chronically inflamed cells. Chronic inflammatory disease account for 90% of the 4.8 Trillion of all US medical spending. These drugs solve it as the results keep rolling in. Even Amazon will not make much of a dent. Thais platform is a ready made , fully integrated marketer

User Image AceBeck Posted - 1 week ago

$LFMD Buying this in the 4 again would be nice

User Image LovetheSqueeze Posted - 1 week ago

$LFMD …this is the most volatile ride ever with this stock. Not for the feint hearted or Mom and Pop counting their retirement nest egg. It follows no ‘real’ price point or action to match the fundamentals and market effects. There’s definitely some spooked, and some profit taking this morning. Shake the tree, and off we go again.

User Image Jasooon Posted - 1 week ago

$LFMD $HIMS Facts 👇 https://x.com/riyadosofian/status/1857081198150926424?s=46&t=7vIazpOiaR63N_ccf3b54A

Analyst Ratings
Cantor Fitzgerald Overweight Sep 20, 24
Cantor Fitzgerald Overweight Aug 20, 24
Cantor Fitzgerald Overweight Aug 9, 24
Keybanc Overweight Jul 11, 24
Keybanc Overweight Jun 5, 24
B. Riley Securities Buy May 21, 24
HC Wainwright & Co. Buy May 10, 24
Cantor Fitzgerald Overweight May 9, 24
BTIG Buy Apr 23, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Jindal Piyush Director Director Nov 06 Option 2.52 37,500 94,500 337,500 11/08/23
Velge Bertrand Director Director Jun 07 Buy 2.41 73,965 178,256 213,465 09/01/23
Velge Bertrand Director Director Nov 02 Buy 3.76 132,072 496,591 349,482 08/31/23
Alvarez Nicholas P Chief Acquisition Of.. Chief Acquisition Officer Jun 14 Buy 2.92 10,712 31,279 180,000 06/15/23
Yecies Eric Harold General Counsel & CC.. General Counsel & CCO Jun 13 Buy 2.6 11,500 29,900 62,500 06/14/23
Velge Bertrand Director Director Jun 05 Buy 2.17 139,500 302,715 139,500 06/07/23
Galluppi Stefan Chief Innovation Off.. Chief Innovation Officer May 23 Buy 2.17 4,608 9,999 12,449 05/31/23
Schreiber Justin CEO CEO May 22 Buy 2.11 50,000 105,500 2,844,620 05/24/23
DiTrolio Joseph Director Director Mar 10 Buy 3.28 2,000 6,560 24,500 03/11/22
Benathen Marc David Chief Financial Offi.. Chief Financial Officer Aug 18 Buy 7.29 3,067 22,358 19,723 08/18/21